Lv61
2578 积分 2023-03-20 加入
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B
1个月前
已完结
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial
1个月前
已完结
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
1个月前
已完结
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
1个月前
已完结
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
3个月前
已完结
Association between chemotherapy-induced myelosuppression and curative efficacy of 2-cycle chemotherapy in small cell lung cancer
3个月前
已完结
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
4个月前
已完结
Complications of extensive adhesion formation after intraperitoneal chemotherapy
4个月前
已关闭
Safety and Tolerability of Interval Compressed Chemotherapy Schedule in Children Receiving Treatment for Ewing Sarcoma: A Real-world Experience From India
6个月前
已关闭
G-CSF improving combined whole brain radiotherapy and immunotherapy prognosis of non-small cell lung cancer brain metastases
6个月前
已完结